# PALD1

## Overview
The PALD1 gene encodes the protein phosphatase domain containing paladin 1, commonly referred to as paladin. This protein is characterized by its unique structure, which includes two putative protein tyrosine phosphatase (PTP) domains, although it functions as a pseudophosphatase due to its lack of catalytic activity (Nitzsche2020Paladin). Paladin is primarily involved in regulating endosomal signaling and angiogenesis, acting as a negative regulator of vascular endothelial growth factor receptor 2 (VEGFR2) signaling (Nitzsche2020Paladin). It is localized in endosomal vesicles and Golgi compartments, where it influences cellular processes such as endothelial cell proliferation and survival (Nitzsche2020Paladin). Additionally, paladin is implicated in various signaling pathways, including insulin signaling and the Hedgehog pathway, and plays a role in embryonic development and cancer metastasis (Rademaker2022Paladin; Egaña2017Female). The protein's interactions and regulatory functions make it a potential therapeutic target in diseases such as cancer and vascular disorders.

## Structure
PALD1, also known as phosphatase domain containing paladin 1, is a protein characterized by the presence of two putative protein tyrosine phosphatase (PTP) domains with the signature motif CxxxxxR, although it does not exhibit typical phosphatase activity (Ruckert2019Protein; Alonso2016The). These domains are classified as PTP-like phytase (PTP-LP) types, which are a type of phosphatase that hydrolyzes myoinositol hexakisphosphate, but PALD1 itself has not shown activity on these substrates (Alonso2015The). The protein contains four CxxxxxR motifs, with two PTP domains showing high similarity to the extended conserved signature motif for PTP active sites (Nitzsche2020Paladin).

PALD1 is myristoylated at a glycine residue at position 2, a modification crucial for its ciliary targeting, facilitated by the myristoyl chaperone Unc119 (May2020Timeresolved). This post-translational modification is significant for its localization and function. PALD1 is expressed in endothelial cells and is involved in various signaling pathways, including insulin signaling and angiogenesis (Egaña2017Female; Nitzsche2020Paladin). The protein is also associated with neural crest formation and migration, indicating its role in embryonic development (Bhattacharyya2019GenomeWide). Despite its classification, PALD1 is often described as a pseudophosphatase due to its lack of catalytic activity (Nitzsche2020Paladin).

## Function
PALD1, also known as paladin, is a PI(4,5)P2 phosphoinositide phosphatase that plays a significant role in regulating endosomal signaling and angiogenesis. It is primarily localized in endosomal vesicles and Golgi compartments, where it interacts with vascular endothelial growth factor receptor 2 (VEGFR2) to modulate its signaling pathways. PALD1 acts as a negative regulator of VEGFR2 signaling by controlling the rate of VEGFR2 internalization and endosomal trafficking, which is crucial for maintaining vascular integrity and preventing excessive angiogenesis (Nitzsche2020Paladin).

In healthy human cells, PALD1 is involved in endothelial cell proliferation and survival, particularly during development. It is expressed in endothelial cells and is associated with vesicular structures such as Rab4 and Rab11-positive vesicles, indicating its role in vesicular membrane dynamics and endosomal signaling pathways (Nitzsche2020Paladin). PALD1 also negatively regulates insulin receptor signaling by affecting the expression and phosphorylation of the insulin receptor and its downstream target, AKT, suggesting its involvement in broader cellular signaling processes (Egaña2017Female; Nitzsche2020Paladin).

## Clinical Significance
The PALD1 gene, encoding the protein paladin, has been implicated in several diseases due to its altered expression or mutations. In colon cancer, PALD1 is overexpressed and associated with poor survival outcomes. Its elevated expression correlates with alterations in key oncogenes such as APC, KRAS, PIK3CA, and TP53, and is linked to cancer cell migration and metastasis, particularly to the liver. This suggests that PALD1 could serve as a potential biomarker for tumor progression and a therapeutic target, although specific inhibitors have not yet been identified (Rademaker2022Paladin).

In the context of lung diseases, PALD1 plays a significant role in lung vascular development and function. Female mice lacking PALD1 exhibit increased endothelial cell apoptosis and emphysema-like histology, indicating a sex-specific effect on lung health. This suggests that PALD1 mutations or expression alterations could have clinical significance in the development of emphysema and chronic obstructive pulmonary disease (COPD), particularly in females (Egaña2017Female). The absence of PALD1 leads to changes in lung structure, similar to those seen in emphysema, highlighting its potential role in maintaining normal lung function (Egaña2017Female).

## Interactions
PALD1, encoded by the PALD1 gene, is involved in various protein interactions that influence cellular processes. In the context of colon cancer, PALD1 interacts with the phosphatase SSH1, which is involved in actin dynamics by activating cofilin. This interaction is significant for actin polymerization and metastasis dissemination in colon cancer cells (Rademaker2022Paladin).

PALD1 also plays a role in the Hedgehog (Hh) signaling pathway, where it accumulates in primary cilia in response to Hh signals. Although PALD1 does not directly interact with the protein SMO, its ciliary accumulation is dependent on SMO activation, suggesting a response to downstream signaling events rather than a direct interaction (May2020Timeresolved).

In vascular biology, PALD1 is involved in regulating VEGFR2 signaling. It forms a complex with VEGFR2 in response to VEGF-A treatment, influencing VEGFR2 internalization and signaling pathways. This interaction is crucial for modulating angiogenesis and endothelial cell functions (Nitzsche2020Paladin).

These interactions highlight PALD1's role in various signaling pathways and its potential as a therapeutic target in diseases such as cancer and vascular disorders.


## References


[1. (Alonso2015The) Andrés Alonso and Rafael Pulido. The extended human <scp>ptp</scp>ome: a growing tyrosine phosphatase family. The FEBS Journal, 283(8):1404–1429, December 2015. URL: http://dx.doi.org/10.1111/febs.13600, doi:10.1111/febs.13600. This article has 87 citations.](https://doi.org/10.1111/febs.13600)

[2. (Egaña2017Female) Isabel Egaña, Hiroshi Kaito, Anja Nitzsche, Lore Becker, Carolina Ballester-Lopez, Colin Niaudet, Milena Petkova, Wei Liu, Michael Vanlandewijck, Alexandra Vernaleken, Thomas Klopstock, Helmut Fuchs, Valerie Gailus-Durner, Martin Hrabe de Angelis, Helge Rask-Andersen, Henrik J. Johansson, Janne Lehtiö, Liqun He, Ali Ö. Yildirim, Mats Hellström, Antonio Aguilar-Pimentel, Markus Ollert, Carsten Schmidt-Weber, Oana Amarie, Jochen Graw, Johannes Beckers, Lillian Garrett, Sabine M. Hölter, Annemarie Zimprich, Wolfgang Wurst, Kristin Moreth, Raffi Bekeredjian, Frauke Neff, Julia Calzada-Wack, Ildikó Rácz, Andreas Zimmer, Birgit Rathkolb, Eckhard Wolf, Jan Rozman, Martin Klingenspor, Tobias Stoeger, Oliver Eickelberg, Irina Treise, Dirk H. Busch, Manuela Östereicher, Ralph Steinkamp, Christoph Lengger, Holger Maier, Claudia Stoeger, and Stefanie Leuchtenberger. Female mice lacking pald1 exhibit endothelial cell apoptosis and emphysema. Scientific Reports, November 2017. URL: http://dx.doi.org/10.1038/s41598-017-14894-9, doi:10.1038/s41598-017-14894-9. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-14894-9)

3. (Nitzsche2020Paladin) Paladin is a PI(4,5)P2phosphoinositide phosphatase that regulates endosomal signaling and angiogenesis. This article has 0 citations.

[4. (Rademaker2022Paladin) Gilles Rademaker, Brunella Costanza, Sébastien Pyr dit Ruys, Raphaël Peiffer, Ferman Agirman, Naïma Maloujahmoum, Didier Vertommen, Andrei Turtoi, Akeila Bellahcène, Vincent Castronovo, and Olivier Peulen. Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination. Oncogenesis, July 2022. URL: http://dx.doi.org/10.1038/s41389-022-00416-4, doi:10.1038/s41389-022-00416-4. This article has 1 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-022-00416-4)

[5. (Alonso2016The) Andrés Alonso, Caroline E. Nunes-Xavier, Yolanda Bayón, and Rafael Pulido. The Extended Family of Protein Tyrosine Phosphatases, pages 1–23. Springer New York, 2016. URL: http://dx.doi.org/10.1007/978-1-4939-3746-2_1, doi:10.1007/978-1-4939-3746-2_1. This article has 24 citations.](https://doi.org/10.1007/978-1-4939-3746-2_1)

6. (May2020Timeresolved) Time-resolved proteomic profiling of the ciliary Hedgehog response reveals that GPR161 and PKA undergo regulated co-exit from cilia. This article has 4 citations.

[7. (Ruckert2019Protein) Mariana Tannús Ruckert, Pamela Viani de Andrade, Verena Silva Santos, and Vanessa Silva Silveira. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma. Cellular and Molecular Life Sciences, 76(13):2571–2592, April 2019. URL: http://dx.doi.org/10.1007/s00018-019-03095-4, doi:10.1007/s00018-019-03095-4. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03095-4)

[8. (Bhattacharyya2019GenomeWide) Teerna Bhattacharyya and Ramanathan Sowdhamini. Genome-wide search for tyrosine phosphatases in the human genome through computational approaches leads to the discovery of few new domain architectures. Evolutionary Bioinformatics, January 2019. URL: http://dx.doi.org/10.1177/1176934319840289, doi:10.1177/1176934319840289. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1176934319840289)